About
SSI Diagnostica Group is a global leader in developing, manufacturing, and distributing in vitro diagnostic (IVD) products, focusing on infectious and tropical diseases. Headquartered in Hillerød, Denmark, the company operates facilities in Denmark, the United States, and China, employing over 600 people worldwide. It was originally part of the Danish National Reference Center and is now privately held by Adelis Equity. The company specializes in producing high-quality antisera for vaccine development and rapid diagnostic tests for disease surveillance and diagnosis. Its product portfolio addresses gastrointestinal, respiratory, and bloodborne diseases, including tropical diseases like dengue. SSI Diagnostica comprises four companies: SSI Diagnostica A/S, TECHLAB®, CTK Biotech, and Beijing Genesee Biotech, Inc., each contributing to its extensive range of diagnostic solutions. The company has seen significant growth since its establishment in 2016, particularly in response to the COVID-19 pandemic, where it developed high-quality rapid tests at scale.
Technologies
Keywords
Company Information
- Employees130
- Founded2016
- Annual Revenue$850000000
Location
2 Herredsvejen, Hillerod, Capital Region of Denmark, Denmark, 3400
